Parallax Volatility Advisers, L.P. Argenx Se Put Options Transaction History

Parallax Volatility Advisers, L.P.

5 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q3 2024 Nov 14, 2024	BUY	$434.22 - $551.9 $4.47 Million - $5.68 Million	10,300 New	10,300 $5.59 Million
Q1 2024 May 15, 2024	BUY	$356.95 - $413.29 $3.86 Million - $4.46 Million	10,800 Added 133.33%	18,900 $7.44 Million
Q4 2023 Feb 14, 2024	BUY	$338.91 - $506.01 $2.75 Million - $4.1 Million	8,100 New	8,100 $3.08 Million
Q4 2020 Feb 16, 2021	SELL	$248.13 - $308.36 $471,447 - $585,884	-1,900 Reduced 76.0%	600 $177,000
Q3 2020 Nov 13, 2020	BUY	$215.51 - $272.51 $538,775 - $681,275	2,500 New	2,500 $660,000

400

30.9M

376K

489K

Ticker ARGX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 55,323,800
Market Cap $31.2B
Description
argenx SE, a biotechnology company, focuses on developing various therapies for the treatment of autoimmune diseases in the United States, the Netherlands, Belgium, Japan, Switzerland, Germany and France. Its lead product candidate is efgartigimod for the treatment of patients with myasthenia gravis, immune thrombocytopenia, pemphigus vulgaris, ...

Get notified when there are updates to the investment portfolio of Parallax Volatility Advisers, L.P., based on Form 13F filings with the SEC.

Stay updated on Parallax Volatility Advisers, L.P. with notifications on news.